This article is more than 5 years old. Information may no longer be current.

Inotek reports $68 million net loss in 2015

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Inotek Pharmaceuticals reported a net loss of $68 million in 2015 compared with $9.5 million in 2014, according to a press release.

This included “$42.8 million in non-cash expenses associated with marking the 2020 convertible notes derivative liability to market value at the time of the conversions,” the release said.

Loss from operations was reported at $20.4 million in 2015 compared with $7.7 million in 2014.

Research and development expenses were reported at $12.6 million in 2015 compared with $5.6 million in 2014. General and administrative expenses were reported at $7.8 million in 2015 compared with $2.1 million in 2014.